Afterload reduction by enflurane.

N Franke; K van Ackern; K Peter

Home/Archive/PubMed

PubMed · 317625

Afterload reduction by enflurane.

N Franke·K van Ackern·K Peter

View original source ↗Export metadata ↓

Abstract

In 12 patients with coronary artery disease, hypertensive period during aortocoronary bypass grafting were treated with enflurane. The effects of enflurane on the general hemodynamic and the major determinants of myocardial oxygen consumption were studied. Heart rate and systolic arterial pressure were significant reduced, cardiac index and pulmonary capillary wedge pressure remained unchanged. The calculated determinants of myocardial oxygen consumption decreased, as well as the measured arterial-coronary venous oxygen content difference. The authors conclude, that enflurane can reduce the afterload in patients with coronary heart disease.

Explore related subjects

Coronary Artery Bypass Coronary Disease Enflurane Humans Middle Aged Myocardial Contraction Oxygen Consumption Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

N Franke, K van Ackern, K Peter. 1979. Afterload reduction by enflurane.. https://pubmed.ncbi.nlm.nih.gov/317625/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Invited commentary.

Explore the source record for details and available documents.

Coronary Artery Bypass↗

PubMed2007

Surgical damage of the saphenous vein and graft patency.

Explore the source record for details and available documents.

Coronary Artery Bypass↗

PubMed2007

Current trends in coronary artery disease in women.

PURPOSE OF REVIEW: There are some striking sex differences regarding presentation, symptoms and sign, diagnosis, and treatment of coronary artery disease. Historically, healthcare delivery to women has been plagued with treatment bias favoring men. This review will present relevant cardiovascular physiologic sex differences, current treatment options for coronary artery disease both surgical and medical, and clinical outcomes of such treatments. RECENT FINDINGS: In the past, pharmacologic and interventional studies generally excluded women from their subjects. As a result, women have been traditionally treated based on the findings in their male counterparts. Recent studies examining sex differences in the treatment of coronary artery disease have given new insight into the hormonal and behavioral influences associated with coronary artery disease. Finally, these studies have drawn attention to possibly inadvertent discrepancies in the way men and women are treated for coronary artery disease. SUMMARY: Despite significant advances in medical and surgical approaches to treat coronary artery disease, it remains and will continue to be the most important healthcare challenge of the 21st century. Whereas efforts are underway to encourage inclusion of more women in therapeutic trials, the educational process, particularly in medical school, needs to broadly address sex specific pathophysiology and treatment, rather than relying on sub-subspecialty training for optimizing healthcare delivery in women.

Coronary Artery Bypass↗